 |
answer text |
<p>We have no plans to set such targets or goals.</p><p> </p><p> </p><p> </p><p>Off-patent
drugs are those whose patent period has expired and they are widely used in the National
Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed
indication(s) to individual patients where doctors consider it is clinically appropriate
to do so. Prescribing decisions are rightly a matter for clinicians in discussion
with their patients.</p><p> </p><p> </p><p> </p><p>We are in the process of setting
up a round-table discussion with key stakeholders, including NHS England and the National
Institute for Health and Care Excellence to explore opportunities for supporting appropriate
use of off-label drugs outside their licensed indications where the evidence supports
this.</p><p> </p>
|
 |
